Company Filing History:
Years Active: 2003-2011
Title: Kurt Klimpel: Innovator in Immunogenic Response Technologies
Introduction
Kurt Klimpel is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of immunology, particularly in the development of methods for producing protective antigens. With a total of 3 patents, his work focuses on enhancing immune responses to combat bacterial infections.
Latest Patents
Kurt Klimpel's latest patents include innovative methods for producing and recovering protective antigens (PA). One of his inventions relates to modified PA that is protease resistant, which is crucial for eliciting an immunogenic response in humans. This technology aims to provide protection against severe bacterial infections, including inhalation anthrax, cutaneous anthrax, and gastrointestinal anthrax. Another significant patent involves a vaccine designed to induce an immune response in mammals to specific antigens. This vaccine comprises a unit dose of a binary toxin protective antigen and the antigen bound to a protective antigen binding protein, facilitating effective immunization.
Career Highlights
Kurt Klimpel works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His career is marked by a commitment to advancing public health through innovative research and development in immunology.
Collaborations
Kurt has collaborated with esteemed colleagues such as Stephen H. Leppla and Theresa J. Goletz. Their combined expertise has contributed to the success of various projects aimed at improving immunogenic responses.
Conclusion
Kurt Klimpel's work in the field of immunology exemplifies the impact of innovative thinking on public health. His patents and collaborations continue to pave the way for advancements in the prevention and treatment of bacterial infections.